James H. Stanker

Companies

• Processa Pharmaceuticals, Inc.Chief financial officer Oct 2, 2020 to Aug 2, 2024¹
• GSE SYSTEMS INCBoard member Aug 8, 2016 to Jun 12, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPProcessa Pharmaceuticals, Inc. PCSA6,482 shares³$11.2K at $1.73Jul 10, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 10, 2024Shares withheld for tax 282 shares at $1.71 of Processa Pharmaceuticals, Inc.³
• Jul 10, 2024Exercised options 644 shares of Processa Pharmaceuticals, Inc.³
• Apr 5, 2024Shares withheld for tax 518 shares at $2.79 of Processa Pharmaceuticals, Inc.³
• Apr 5, 2024Exercised options 1,675 shares of Processa Pharmaceuticals, Inc.³
• Jan 1, 2024Shares withheld for tax 518 shares at $2.79 of Processa Pharmaceuticals, Inc.⁴
• Jan 1, 2024Exercised options 1,675 shares of Processa Pharmaceuticals, Inc.⁴
• Oct 12, 2023Granted 15,000 shares at $0.33 of Processa Pharmaceuticals, Inc.⁵
• Oct 10, 2023Granted 22,500 shares at $0.24 of Processa Pharmaceuticals, Inc.⁶
• Feb 9, 2023Granted 12,500 shares at $0.80 of Processa Pharmaceuticals, Inc.⁷
• Aug 5, 2022Shares withheld for tax 2,462 shares at $3.17 of Processa Pharmaceuticals, Inc.⁸
• Aug 5, 2022Exercised options 7,601 shares of Processa Pharmaceuticals, Inc.⁸